Carregant...
Immune checkpoint inhibitors: Real-world experience from India in advanced solid cancers that have progressed on chemotherapy
CONTEXT: The immune checkpoint inhibitors (ICIs) nivolumab and pembrolizumab have shown dramatic efficacy with low toxicity in international studies of advanced solid cancers. No published Indian experience with ICIs exist other than isolated case reports. AIMS: The aim of this study is to evaluate...
Guardat en:
| Publicat a: | South Asian J Cancer |
|---|---|
| Autors principals: | , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Medknow Publications & Media Pvt Ltd
2019
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6348784/ https://ncbi.nlm.nih.gov/pubmed/30766859 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/sajc.sajc_167_18 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|